logo

Neurometrix Inc (NURO)



Trade NURO now with
  Date
  Headline
10/31/2017 10:09:02 AM NeuroMetrix Closes $3.5 Mln Equity Offering
10/19/2017 7:07:10 AM NeuroMetrix Q3 Revenue Up 5% To $3.5 Mln
7/20/2017 7:05:39 AM NeuroMetrix Q2 Net Loss $3.24 Mln Vs Loss $4.09 Mln Year Ago
6/13/2017 7:03:15 AM NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology
4/20/2017 7:12:31 AM NeuroMetrix Q1 Loss Per Share $0.91 Vs Loss $1.00 Prior Year
1/26/2017 7:12:52 AM NeuroMetrix Q4 Loss/shr Narrows To $0.52 From $3.19 Last Year
12/20/2016 8:06:49 AM NeuroMetrix Prices Public Offering With Expected Gross Proceeds $26.5 Mln
11/29/2016 7:02:19 AM NeuroMetrix Gets CE Mark Certification For Quell Wearable Pain Relief Device
10/27/2016 7:14:35 AM NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology
10/20/2016 7:01:33 AM NeuroMetrix Q3 Loss Per Share $0.76 Vs Loss $1.06 Last Year
9/13/2016 7:00:31 AM NeuroMetrix Reports Final Approval To Market DPNCheck In China
7/21/2016 7:10:37 AM NeuroMetrix Q2 Total Revenues $2.65 Mln Vs. $1.22 Mln Last Year
6/28/2016 11:34:36 AM NeuroMetrix Announces Quell Distribution Agreement With WBC Group
6/22/2016 7:03:16 AM NeuroMetrix Submits CE Mark Application For Quell Wearable Pain Relief Device
4/21/2016 7:25:35 AM NeuroMetrix Q1 Total Revenues $2.28 Mln Vs $1.28 Mln Last Year
1/28/2016 7:21:25 AM NeuroMetrix Q4 Loss Narrows To $2.71 Mln From $2.91 Mln Last Year
1/21/2016 7:09:50 AM NeuroMetrix Reports Regulatory Approval In China For DPNCheck, A Diagnostic Test For Peripheral Neuropathy
1/14/2016 7:10:57 AM NeuroMetrix Announces High Level Of Interest In Quell, 100% Drug Free Chronic Pain Relief Wearable At CES 2016
1/11/2016 7:18:26 AM NeuroMetrix Expects Q4 Revenue At $2.7 Mln
  
 
>